BI

Balu Iyyappan

Active Director Director DIN 08135728
DIN 08135728 First appointment May 2018 Primary industry Professional Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Balu Iyyappan

Data last updated:

Balu Iyyappan is a Director at Urora Pharmaceuticals Private Limited (since 2018). The company operates in Professional Services. Urora Pharmaceuticals Private Limited reported revenue of ₹1.4 Lakh (FY 2019).

DIN 08135728
Primary Designation Director
Industry Professional Services
First Appointment 17 May 2018
Oldest Company Age 8 yrs
Largest company Urora Pharmaceuticals Private Limited · ₹1.4 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 May 20182018₹1.4 Lakh (FY 2019)Active

Board colleagues of Balu Iyyappan

NameDINCompanyDesignation
Iyyappan Vanithamani08135729Urora Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Urora Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Balu Iyyappan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balu Iyyappan

Balu Iyyappan currently holds 1 directorship: Urora Pharmaceuticals Private Limited (Director, since 17 May 2018, revenue ₹1.4 Lakh (FY 2019)).

Balu Iyyappan was first appointed on 17 May 2018 as Director at Urora Pharmaceuticals Private Limited.

The current boards of Balu Iyyappan's companies include Iyyappan Vanithamani (Urora Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available